Ascendis Pharma

Ascendis Pharma

Ascendis Pharma is a global biopharmaceutical company headquartered in Hellerup, Denmark. The company focuses on developing innovative therapies through its proprietary TransCon drug delivery platform, designed to improve patient outcomes by maintaining consistent medication levels over time. With a portfolio spanning endocrinology, oncology, and rare diseases, Ascendis has grown from a Danish startup into an international commercial-stage company with expanding operations across Europe, the US, and beyond.

Company History

Founded in 2006 as a biotechnology company, Ascendis Pharma has developed the TransCon platform to create best-in-class therapies. It launched its first product, Skytrofa, for pediatric growth hormone deficiency, and continues to expand its pipeline and global footprint.

For International Professionals

  • Ascendis Pharma has an international workforce, with employees from over 30 nationalities, making it a multicultural environment where English is the working language.
  • The Spain office is a hub for European medical affairs and public affairs roles, providing a central location for professionals seeking involvement in European healthcare strategy.
  • With a focus on scientific innovation, employees have the opportunity to contribute to pipeline projects and product launches that impact patients with serious diseases.
  • As a Danish company, it offers a balanced work culture that values work-life balance, with flexible working arrangements for hybrid roles.

Open Positions (2)